metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Right hepatic artery pseudoaneurysm due to cholecystitis
Journal Information
Vol. 101. Issue 9.
Pages 650-653 (September 2023)
Share
Share
Download PDF
More article options
Vol. 101. Issue 9.
Pages 650-653 (September 2023)
Scientific letter
Full text access
Right hepatic artery pseudoaneurysm due to cholecystitis
Pseudoaneurisma de arteria hepática derecha secundario a colecistitis
Visits
71
Marina Esgueva Anguloa,
Corresponding author
, Arkaitz Perfecto Valeroa,b, Mikel Prieto Calvoa,b,c, Alberto Ventoso Castiñeiraa,b, Andrés Valdivieso Lópeza,b,c
a Servicio de Cirugía General y del Aparato Digestivo, Hospital Universitario Cruces, Instituto de Investigación Sanitaria BioCruces, Bizkaia, Spain
b Unidad de Cirugía Hepatobiliar y Trasplante Hepático
c Universidad del País Vasco, Bizkaia, Spain
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Figures (1)
Tables (1)
Table 1. Cases published in the international literature of RHApA in the context of cholecystitis. M = male; F = female; US = ultrasound; CT = computed tomography; ERCP = endoscopic retrograde cholangiopancreatography; pre-op = before surgery; post-op = after surgery; POD = postoperative day.
Full Text

Splanchnic aneurysms are rare, with an estimated incidence of 0.1%–2%. The most common presentations are located in the splenic artery (60%), followed by the hepatic artery (HA) (20%). HA aneurysms are mainly extrahepatic (75%–80%) and affect the common hepatic artery (63%); aneurysms of its branches are less common (23% right hepatic artery [RHA], 5% left hepatic artery, 4% bilateral).1

The main cause of true aneurysms is atherosclerosis.1–3 However, the percentage of pseudoaneurysms is increasing due to the generalization of percutaneous and endoscopic techniques, while their development secondary to inflammatory and/or infectious processes is unusual2–8 Unlike aneurysms, pseudoaneurysms grow relatively quickly, making early diagnosis and treatment important.

We present a case of RHA pseudoaneurysm (RHApA) secondary to cholecystitis:

The patient is a 46-year-old Asian woman with a history of biliary colic managed with traditional Chinese medicine. She consulted for abdominal pain and melena. On examination, she presented discomfort on palpation in the mesogastrium, with no peritonism. Analytically, she presented anemia, slightly elevated transaminases and mild neutrophilia, with no leukocytosis.

The Glasgow-Blatchford9 score showed a high risk of upper gastrointestinal bleeding (10 points). Gastroscopy was performed, showing no evidence of active bleeding. Computed tomography (CT) found exacerbated chronic cholecystitis. Within 48 h, she presented rectal bleeding that required transfusion, and CT angiography revealed a cholecystocolic fistula with no signs of active bleeding (Fig. 1A). On the 6th day of hospitalization and due to hemodynamic instability, the CT angiography was repeated, which showed active hemorrhage within the gallbladder (Fig. 1B). Urgent arteriography was indicated, demonstrating a RHApA (Fig. 1C), which was embolized with coils (Fig. 1D). Subsequently, another CT scan confirmed the exclusion of the pseudoaneurysm and correct bilateral hepatic perfusion. Liver function remained stable, with no laboratory abnormalities for bilirubin or transaminase levels. An exploratory laparotomy was performed 4 days later, which confirmed the presence of the cholecystocolic fistula and a communication between the HA and the gallbladder fundus; the coils were also observed inside the gallbladder lumen. Standard cholecystectomy was performed with suture of the cholecystocolic fistula using interrupted stitches. The postoperative period was uneventful, and the patient was discharged on the 10th day. The pathology report confirmed chronic cholecystitis.

Fig. 1.

(A) Acute cholecystitis over chronic cholecystopathy associated with cholecystocolic fistula; (B) active hemorrage in the gallbladder; (C) RHApA; (D) post-embolization arteriography with coils. GB = gallbladder; CCF = cholecystocolic fistula; LHA = left HA; HAP = HA proper; CA = cystic A; CHA = common HA; GDA = gastroduodenal A.

(0.29MB).

The diagnosis of hepatic artery aneurysm is usually incidental, and abdominal and/or lumbar pain are the main associated symptoms.1 The risk of rupture is greater in pseudoaneurysms.1,3 Quincke’s classic triad,4 consisting of pain in the right hypochondrium, gastrointestinal bleeding and jaundice due to hemobilia occurs in less than one-third of patients. The general incidence of rupture is around 25%, with mortality rates between 20% and 70%, depending on the series.1 In addition, the fibrinolytic action of bile favors the development of hemorrhagic shock. Although arteriography is the gold standard,4,8 the diagnostic test of choice is CT angiography, as it is less invasive and has high sensitivity and specificity.2,3,10 As this is an infrequent pathology, there is no consensus on management, but treatment is recommended for all pseudoaneurysms regardless of size or symptoms due to the increased risk of rupture.1,3

The presence of a cystic artery pseudoaneurysm (CApA) in the context of cholecystitis is a rare condition. It has been suggested that visceral inflammation adjacent to the vascular wall can cause injury to the adventitia and thrombosis of the vasa vasorum,4,10 contributing to the appearance of pseudoaneurysms. In a recent review, Patil et al.10 have reported a total of 59 CApA. To our knowledge, RHApA seem to be even more exceptional, as we have only found 6 cases published in the international literature (Table 1).2,4–8

Table 1.

Cases published in the international literature of RHApA in the context of cholecystitis. M = male; F = female; US = ultrasound; CT = computed tomography; ERCP = endoscopic retrograde cholangiopancreatography; pre-op = before surgery; post-op = after surgery; POD = postoperative day.

  Author  Reference  Age  Sex  Symptoms  Complementary studies  RHApA diagnosis  Rupture on diagnosis  Embolization  Surgery  Follow-up 
Poon et al.  GIE, volume 51, no. 4, part 1, 2000  78  Fever  Gastroscopy  Arteriography  Yes  Yes (post-op)  Exploratory laparotomy  Discharge 10th POD, asymptomatic 3 months 
          Abdominal pain  CT           
          Melena  Arteriography           
Akatsu et al.  J Gastroenterol 2004; 39:900–903  64  Abdominal pain  Gastroscopy  Arteriography  Yes  Yes (pre-op)  Open cholecystectomy + Roux-en-Y  Asymptomatic 5 years 
          Hematemesis  Doppler US           
          Melena  CT           
            Arteriography           
Lin et al.  Clin Gastroenterol Hepatol. 2009 Dec;7(12):e73  73  Jaundice  Gastroscopy  Intraoperative  No  Yes (post-op)  Open cholecystectomy + ligation aneurysm  Asymptomatic 2 years 
          Abdominal pain  ERCP           
          Melena  MRI           
Ramirez-Maldonado et al.  Surg Case Rep. 2011 Mar 1;2011(3):4  70  Abdominal pain    CT  Yes  Yes (pre-op)  Open cholecystectomy  Right hepatectomy due to ischemia 28th POD 
Das et al.  SAGE Open Medical Case Reports. January 2019.  72  Abdominal pain  US  Arteriography  Yes  Yes (pre-op)  Reconverted subtotal cholecystectomy  – 
          Vomiting  Gastroscopy           
            ERCP           
            CT           
            Arteriography           
Sawalha et al.  JIMHICR January 2020.  80  Abdominal pain  CT  Arteriography  No  Yes (pre-op)  Open cholecystectomy + fistula closure  Exitus 
          Melena  Arteriography           
Esgueva et al.  –  46  Abdominal pain  CT  Arteriography  Yes  Yes (pre-op)  Open cholecystectomy + fistula closure  Asymptomatic 1 month 
          Melena  Gastroscopy           
            Arteriography           

According to the review of experiences reported on RHApA due to cholecystitis,2,4–8 mean patient age is 72.8 years, with a predominance of females (3:1). The predominant symptom is abdominal pain (100%),2,4–8 followed by UGI bleeding (melena 66.6%,2,4–6 hematemesis 16.6%5). Fever is infrequent (16.6%).4 Presentation as cholecystobiliary fistula (Mirizzi syndrome grade V) occurred in 2 patients (33.3%).2,4 In 3 cases (33.3%), bleeding through Vater’s papilla was observed on gastroscopy.5,6 The diagnosis of RHApA was made by CT in one case7 (16.6%), while 66.6% required arteriography.2,4,5,8 In one case, the pseudoaneurysm was found intraoperatively.6 Preoperative embolization was performed in 66.6%,2,5,7,8 and in the other 2 cases during the postoperative period.4,6 Cholecystectomy was completed in 83.3% of cases.2,5–8 In one case of cholecystoduodenal fistula, embolization was technically impossible to perform due to uncontrollable bleeding, requiring postoperative embolization of the RHApA and deferred cholecystectomy.4 One patient died during cholecystectomy due to uncontrollable bleeding, despite having undergone prior angioembolization. This patient also had a cholecystocolic fistula.2

Preoperative embolization of both CApA and RHApA reduces the risk of intraoperative bleeding, which may facilitate dissection during cholecystectomy. However, the need to perform cholecystectomy in all cases is the subject of debate. Although there is a risk of gallbladder or even hepatic ischemia, some authors advocate avoiding it in patients with high surgical risk.10

Thus, RHApA are an exceptional entity in the context of cholecystitis, whose diagnostic suspicion must be established in patients with acute cholecystitis and gastrointestinal bleeding. The scarcity of bibliographic references prevents us from establishing a therapeutic algorithm, although initial actions to stabilize the patient are required. Angioembolization presents satisfactory results as an initial measure, stopping bleeding and reducing the risk of intraoperative hemorrhage during cholecystectomy.

Funding

This article has received no specific funding from public, commercial or non-profit sources.

Conflicts of interests

None of the authors have any conflicts of interest to declare.

References
[1]
R.A. Chaer, C.J. Abularrage, D.M. Coleman, M.H. Eslami, V.S. Kashyap, C. Rockman.
Hepatic Artery Aneurysm (HAA). The Society for Vascular Surgery clinical practice guidelines on the management of visceral aneurysms.
Vasc Surg, 72 (2020), pp. 23S-26S
[2]
R.T. Poon, H. Tuen, C. Yeung.
GI hemorrhage from fistula between right hepatic artery pseudoaneurysm and the duodenum secondary to acute cholecystitis.
Gastrointest Endosc, 51 (2000), pp. 491-493
[3]
Kwong J.M. Rockman C.B. Kashyap V.S. Visceral artery aneurysms. Rutherford’s vascular surgery and endovascular therapy. Philadelphia; Elsevier. 9th ed. 1110–1120.
[4]
M. Das, F.-H. Volmar, S. Walayat, R. Nolte.
Hemobilia from a right hepatic artery pseudoaneurysm due to chronic cholecystitis.
SAGE Open Med Case Rep, 7 (2019),
[5]
K. Sawalha, A. Kunnumpurath, R. McCann.
An unusual cause of an intraperitoneal bleed: bleeding hepatic artery pseudoaneurysm due to an eroding cholecystitis.
J Investig Med High Impact Case Rep, 8 (2020),
[6]
S.Z. Lin, C.W. Tseng, C.C. Chen.
Hepatic artery pseudoaneurysm presenting with Mirizzi syndrome and hemobilia.
Clin Gastroenterol Hepatol, 7 (2009), pp. e73
[7]
R. Ramirez-Maldonado, E. Ramos, J. Dominguez, R. Mast, L. Llado, J. Torras, et al.
Pseudoaneurysm of the right hepatic artery and bile duct necrosis as a complication of acute cholecystitis in a diabetic patient.
JSCR, 3 (2011), pp. 4
[8]
T. Akatsu, S. Hayashi, T. Egawa, M. Doi, A. Nagashima, M. Kitano, et al.
Hepatic artery pseudoaneurysm associated with cholecystitis that ruptured into the gallbladder.
J Gastroenterol, 39 (2004), pp. 900-903
[9]
O. Blatchford, W.R. Murray, M. Blatchford.
A risk score to predict need for treatment for upper-gastrointestinal haemorrhage.
Lancet, 356 (2000), pp. 1318-1321
[10]
N.S. Patil, A.H. Kumar, V. Pamecha, T. Gattu, S. Falari, P.K. Sinha, et al.
Cystic artery pseudoaneurysm-a rare complication of acute cholecystitis: review of literature.
Surg Endosc, 36 (2022), pp. 871-880
Copyright © 2022. AEC
Download PDF
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos